Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies

Research in Social and Administrative Pharmacy

Volumn 11, Issue 3, 2015, Pages 412-427

  Hanes, Carissa A ^a   Wong, Keith K H ^a,b,c   Saini, Bandana ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c University of Sydney   (Australia)

Author keywords

Novel services; Obstructive sleep apnea; OSA=obstructive sleep apnea; Practice framework; Professional pharmacy services; Public health

Indexed keywords

AUSTRALIA; FACTUAL DATABASE; HEALTH CARE DELIVERY; HUMAN; JOB SATISFACTION; MOTIVATION; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; POSITIVE END EXPIRATORY PRESSURE; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

AUSTRALIA; COMMUNITY PHARMACY SERVICES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE; HUMANS; JOB SATISFACTION; MODELS, ORGANIZATIONAL; MOTIVATION; PHARMACIES; PHARMACISTS; PROFESSIONAL PRACTICE; PROFESSIONAL ROLE; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84927922771     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2014.08.009     Document Type: Article

References (48)

1. Higby G.J. The continuing evolution of American pharmacy practice, 1952-2002. J Am Pharm Assoc 2002, 42:12-15.
2. Benrimoj S.I., Frommer M.S. Community pharmacy in Australia. Aust Health Rev 2004, 28:238-246.
3. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165:1217-1239.
4. Young T., Evans L., Finn L., Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997, 20:705-706.
5. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
6. Wright J., Johns R., Watt I., Melville A., Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997, 314:851.
7. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G.N. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
8. Marshall N., Wong K., Liu P., Cullen S., Knuiman M., Grunstein R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton health study. Sleep 2008, 31:7.
9. Giles T.L., Lasserson T.J., Smith B., White J., Wright J.J., Cates C.J. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, CD001106.
10. Kryger M.H., Roth T., Dement W.C. Principles and Practice of Sleep Medicine 2011, Saunders/Elsevier, Philadelphia, PA. 5th ed.
11. Sawyer A.M., Gooneratne N.S., Marcus C.L., Ofer D., Richards K.C., Weaver T.E. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 2011, 15:343-356.
12. Hanes C.A., Wong K.K., Saini B. Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience. Int J Clin Pharm 2014, 36:460-468.
13. Flemons W.W., Douglas N.J., Kuna S.T., Rodenstein D.O., Wheatley J. Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med March 15, 2004, 169:668-672.
14. Young T., Peppard P.E., Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005, 99:1592-1599.
15. Peppard P.E., Young T., Barnet J.H., Palta M., Hagen E.W., Hla K.M. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013, 177:1006-1014.
16. Chai-Coetzer C.L., Antic N.A., McEvoy R.D. Ambulatory models of care for obstructive sleep apnea: diagnosis and management. Respirology 2013, 18(4):605-615.
17. Chai-Coetzer C.L., Antic N.A., Rowland L.S., et al. Primary care vs specialist sleep Center management of obstructive sleep apnea and daytime sleepiness and quality of life: a randomized trial. J Am Med Assoc 2013, 309:997-1004.
18. Chai-Coetzer C.L., Antic N.A., Rowland L.S., et al. A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care. Thorax 2011, 66:213-219.
19. Antic N.A., Buchan C., Esterman A., et al. A randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apnea. Am J Respir Crit Care Med 2009, 179:501-508.
20. Hepler C.D., Strand L.M. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990, 47:533-543.
21. Austin Z., Ensom M.H. Education of pharmacists in Canada. Am J Pharm Educ 2008, 72.
22. Practice Guidelines for the Provision of Immunisation Services Within Pharmacy 2013, Pharmaceutical Society of Australia, Accessed 12.08.14. http://www.psa.org.au/download/practice-guidelines/immunisation-guidelines.pdf.
23. Pharmaceutical Society of Australia. Guidelines forPharmacists Issuing Certificates for Absence FromWork. Accessed 12.08.14. http://www.psa.org.au/guidelines/issuing-certificates-for-absence-from-work.
24. Rogers E.M. Diffusion of Innovations 1995, The Free Press, New York. 4th ed.
25. Hanes C.A., Wong K.K., Saini B. An overview of service quality of continuous positive airway pressure services in Australian pharmacies. Respirology 2014, 19:85-91.
26. Donabedian A. Evaluating the quality of medical care. Milbank Q 1966, 44:166-206.
27. Kozma C., Reeder C., Schulz R. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1992, 15:1121-1132.
28. Bowen G.A. Naturalistic inquiry and the saturation concept: a research note. Qual Res 2008, 8:137-152.
29. Ritchie J., Spencer L. Qualitative data analysis for applied policy research. Analyzing Qualitative Data 1994, 173-194. Routledge, New York, NY. A. Bryman, R. Burgess (Eds.).
30. Srivastava A., Thomson S.B. Framework analysis: a qualitative methodology for applied policy research. JOAAG 2009, 4:72-79.
31. Roberts A.S., Benrimoj S.I., Chen T.F., Williams K.A., Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract 2006, 14:163-170.
32. Holdford D., Kennedy D.T., Bernadella P., Small R.E. Implementing disease management in community pharmacy practice. Clin Ther 1998, 20:328-339.
33. Moullin J.C., Sabater-Hernández D., Fernandez-Llimos F., Benrimoj S.I. Defining professional pharmacy services in community pharmacy. Res Soc Adm Pharm 2013, 9:989-995.
34. Robinson L. Enabling Change: A Summary of Diffusion of Innovations 2009, Accessed 12.08.14. http://www.enablingchange.com.au/Summary_Diffusion_Theory.pdf.
35. The Roadmap: The Strategic Direction for Community Pharmacy May 2010, The Pharmacy Guild of Australia, Accessed 12.08.14. http://www.guild.org.au/docs/default-source/public-documents/tab--the-guild/Strategic-Direction/here-pdf?sfvrsn=0.
36. Singleton J.A., Nissen L.M. Future-proofing the pharmacy profession in a hypercompetitive market. Res Soc Adm Pharm 2014, 10:459-468.
37. ASA News December 2012, Australasian Sleep Association, Accessed 12.08.14. http://www.sleep.org.au/documents/item/418.
38. Pharmacy Board of Australia Code Conduct Registered Health Practitioners 1 July 2010, Reviewed 27 July 2012, Accessed 12.08.14. http://www.pharmacyboard.gov.au/Codes-Guidelines.aspx.
39. Code of Ethics for Pharmacists 2011, Pharmaceutical Society of Australia, Accessed 12.08.14. http://www.psa.org.au/download/codes/code-of-ethics-2011.pdf.
40. Tran A., Fuller J., Wong K., Krass I., Grunstein R., Saini B. The development of a sleep disorder screening program in Australian community pharmacies. Pharm World Sci 2009, 31:473-480.
41. Schwegler K., Klaghofer R., Nirkko A.C., Mathis J., Hersberger K.E., Bloch K.E. Sleep and wakefulness disturbances in Swiss pharmacy customers. Swiss Med Wkly 2006, 136:149-154.
42. Perraudin C., Le Vaillant M., Pelletier-Fleury N. Cost-effectiveness of a community pharmacist-led sleep apnea screening Program - A Markov model. PLoS One 2013, 8:e63894.
43. Kashyap K.C., Nissen L.M., Smith S.S., Douglas J.A., Kyle G.J. Can a community pharmacy sleep assessment tool aid the identification of patients at risk of sleep disorders in the community: a pilot study. Integr Pharm Res Pract 2012, 1:3-12.
44. Hersberger K.E., Renggli V.P., Nirkko A.C., Mathis J., Schwegler K., Bloch K.E. Screening for sleep disorders in community pharmacies - evaluation of a campaign in Switzerland. J Clin Pharm Ther 2006, 31:35-41.
45. Fuller J.M., Wong K.K., Krass I., Grunstein R., Saini B. Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Educ Couns 2011, 83:325-335.
46. Epstein L.J., Kristo D., Strollo P.J., et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009, 5:14.
47. Chai-Coetzer C.L., Douglas J., McEvoy D., et al. Guidelines for Sleep Studies in Adults February 2014, Prepared for the Australasian Sleep Association 11, Accessed 12.08.14. http://www.sleep.org.au/documents/item/1009.
48. Fuller J.M., Wong K.K., Grunstein R., Krass I., Patel J., Saini B. A comparison of screening methods for sleep disorders in Australian community pharmacies: a randomized controlled trial. PLoS One 2014, 9:e101003.